Evogene (EVGN) Misses Q1 EPS by 2c

Evogene (NASDAQ: EVGN) reported Q1 EPS of ($0.21), $0.02 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $312 thousand versus the consensus estimate of $230.67 thousand.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• Lumexa Imaging Holdings, Inc. (LMRI) Reports In-Line Q2 EPS; Offers Guidance
• Aptera Motors (SEV) Reports Q2 Loss of $0.20
• Park Dental Partners, Inc. (PARK) Tops Q2 EPS by 28c